Surprisingly, a positive enrichment of the SCLC-N signature (Ireland et al. 2020) was also observed (Fig. 3D) and this signature remained highly expressed during the off-phase of OC2 expression. The gene discussed is ONECUT2; the disease is small cell lung carcinoma.